University of Louisville homepage
All experts
All experts

Dr.

Michael Sowell

Professor Term

School of Medicine

Orcid identifier0009-0003-2039-0309
  • Professor Term
    School of Medicine
  • (502) 588-4800 (Work)
  • University of Louisville Physicians, Neurology, 401 E Chestnut St Unit 510, Louisville, KY, 40202-5710, United States

SPONSORED PROJECTS

Headache Medicine

Adult Neurodevelopmental Disorders

Transitions of Care (Pediatric to Adults Neurology provider)

SPONSORED PROJECTS

  • Showing page 1 out of 1
Showing page 1, sponsored projects 1 to 10 of 10
GRANT
240115|Patient/Caregiver Workshop and Grant to Improve Transition of Care Practices
Child Neurology Foundation_CNF9 Jan 2023
MORELEARN MORE
GRANT
220517A|GN PCORI: CBT Via Telehealth + Amitriptyline Compared to CBT via Telehealth Alone: Pediatric Migraine Prevention Study
Cincinnati Childrens Hosp Medi Ctr_CCHMC1 Jan 2023
MORELEARN MORE
GRANT
220517B|GB PCORI: CBT Via Telehealth + Amitriptyline Compared to CBT via Telehealth Alone: Pediatric Migraine Prevention Study
Cincinnati Childrens Hosp Medi Ctr_CCHMC1 Jan 2023
MORELEARN MORE
GRANT
220517B|GN PCORI: CBT Via Telehealth + Amitriptyline Compared to CBT via Telehealth Alone: Pediatric Migraine Prevention Study
Cincinnati Childrens Hosp Medi Ctr_CCHMC1 Jan 2023
MORELEARN MORE
GRANT
220517|PCORI: CBT Via Telehealth + Amitriptyline Compared to CBT via Telehealth Alone: Pediatric Migraine Prevention Study Synopsis
Cincinnati Childrens Hosp Medi Ctr_CCHMC1 Jan 2023
MORELEARN MORE
GRANT
AWD-00000017|220517C|GB PCORI: CBT Via Telehealth + Amitriptyline Compared to CBT via Telehealth Alone: Pediatric Migraine Prevention Study
Cincinnati Childrens Hosp Medi Ctr_CCHMC1 Jan 2023 - 31 Dec 2026
MORELEARN MORE
GRANT
AWD-00000017|220517C|GN PCORI: CBT Via Telehealth + Amitriptyline Compared to CBT via Telehealth Alone: Pediatric Migraine Prevention Study
Cincinnati Childrens Hosp Medi Ctr_CCHMC1 Jan 2023 - 31 Dec 2026
MORELEARN MORE
GRANT
210294|Protocols TV48125-CNS-30082/83/84: Subcutaneous Administration of Fremanezumab for the Preventive Treatment of Chronic Migraine/Episodic Migraine/Episodic and Chronic Migraine in Pediatric Patients 6 to 17 Years of Age
Teva Pharmaceuticals_TP11 Jan 2021
MORELEARN MORE
GRANT
190568|PEDIATRIC MIGRAINE REGISTRY: A National Registry of Children with Migraines
Duke Clinical Research Institute_DCRI1 Jan 2019
MORELEARN MORE
GRANT
180039|IPX229-B16-01 A Multicenter, Randomized, Double-Blind, Placebo-Controlled. Crossover Study to Evaluate the Efficacy and Safety of Zolmitriptan Nasal Spray for the Treatment of Acute Migraine in Subjects Ages 6 to 11 Years, with an Open-Label Extension
PRA Health Sciences Inc_PRA1 Jan 2018
MORELEARN MORE